DWP
IBB icon

Daymark Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History

Daymark Wealth Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Buy
1,376
+150
+12% +$25.8K 0.01% 669
2026
Q1 		$207K Hold
1,226
– – 0.01% 702
2025
Q4 		$207K Buy
+1,226
New +$199K 0.01% 584
2025
Q1 		– Sell
-1,529
Closed -$202K – 511
2024
Q4 		$202K Sell
1,529
-75
-5% -$10.5K 0.01% 483
2024
Q3 		$234K Hold
1,604
– – 0.01% 478
2024
Q2 		$220K Buy
1,604
+28
+2% +$3.74K 0.01% 468
2024
Q1 		$216K Buy
+1,576
New +$215K 0.01% 403

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Daymark Wealth Partners's IBB Position: Q2 2026 in Review

Daymark Wealth Partners increased its iShares Biotechnology ETF (IBB) stake by 12% in Q2 2026, buying an estimated $25.8K and bringing the position to 1,376 shares worth $262K. The position accounts for 0.01% of the portfolio, ranked #669.

Daymark Wealth Partners first reported a position in IBB in Q1 2024 and has held it in 7 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Daymark Wealth Partners held 1,376 shares of iShares Biotechnology ETF worth $262K as of Q2 2026.
  • Daymark Wealth Partners bought 150 iShares Biotechnology ETF shares in Q2 2026, an estimated $25.8K.
  • iShares Biotechnology ETF made up 0.01% of Daymark Wealth Partners's portfolio in Q2 2026, its #669 holding.
  • Daymark Wealth Partners first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 7 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.